Table 2.
Results of the Collaborative Laboratory Integrated Reports (CLIR) SCAD tool applied to the initial MS/MS profile.
| Clinical Category | Genetic Category | Number | CLIR Applied to MS/MS | ||
|---|---|---|---|---|---|
| SCAD(2M) | Needs 2TT 1 | Not SCAD(2M) | |||
| SCAD | SCAD(2M) | 23 | 5 | 18 | 0 |
| SCAD(2M1P) | 4 | 0 | 4 | 0 | |
| SCAD(2M2P) | 3 | 0 | 3 | 0 | |
| SCAD(het) | SCAD(1M1P) | 24 | 0 | 13 | 11 |
| SCAD(1M2P) | 7 | 0 | 0 | 7 | |
| Not SCAD | SCAD(2P) | 10 | 0 | 3 | 7 |
| SCAD(1P) | 1 | 0 | 1 | 0 | |
| No SCAD variants | 2 | 0 | 2 | 0 | |
| Total | 74 | 5 | 44 | 25 | |
| Reduction in Positives | 33.80% | ||||
1 Second-tier test suggested to provide additional information.